You are here

Seqirus

CDC's ACIP recommends higher dose, Seqirus, Sanofi flu vaccines in adults 65 and older

Endpoints

Thu, 06/23/22 - 07:55 pm

CSL's Seqirus caps off $156M expansion of flu manufacturing facility in Raleigh suburb

Endpoints

Thu, 06/9/22 - 10:23 am

drug manufacturing

Pressing for label change, vaccine giant Sanofi takes Seqirus influenza imbroglio to the FDA

Fierce Pharma

Wed, 03/9/22 - 10:50 am

Sanofi, GSK and Seqirus prep for near-record flu shot sales as COVID's delta variant cooks up 'recipe for disaster'

Fierce Pharma

Wed, 08/25/21 - 12:21 pm

Vaccine maker Seqirus plots $800M investment into major Australian shot manufacturing center

Fierce Pharma

Mon, 11/16/20 - 10:34 pm

drug manufacturing

Seqirus investing $52M, adding 100 jobs to U.K. flu vaccine site prompted by thoughts of pandemics

Fierce Pharma

Sat, 11/11/17 - 11:03 am

drug manufacturing

Flu season early bird Seqirus debuts Fluad TV ad campaign targeting seniors

Fierce Pharma

Wed, 08/23/17 - 10:17 pm

The flu vaccines are coming: GSK, Sanofi ship the first of more than 150M doses headed to U.S.

Fierce Pharma

Wed, 07/19/17 - 10:22 am

First flu vaccine with immune-boosting adjuvant approved for US market

Stat

Wed, 11/25/15 - 11:35 am

immune-boosting adjuvants